The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 04, 2015

Filed:

Feb. 16, 2012
Applicants:

Ross Kedl, Centennial, CO (US);

Phillip J. Sanchez, Centennial, CO (US);

Catherine Haluszczak, Centennial, CO (US);

Inventors:

Ross Kedl, Centennial, CO (US);

Phillip J. Sanchez, Centennial, CO (US);

Catherine Haluszczak, Centennial, CO (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 38/19 (2006.01); A61K 38/21 (2006.01); A61K 39/00 (2006.01); A61K 48/00 (2006.01); A61K 39/245 (2006.01); A61K 39/285 (2006.01); A61K 39/39 (2006.01); A61K 47/48 (2006.01); C07K 14/555 (2006.01); C07K 14/705 (2006.01); C07K 16/28 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 48/00 (2013.01); A61K 39/245 (2013.01); A61K 39/285 (2013.01); A61K 39/39 (2013.01); A61K 47/4833 (2013.01); A61K 47/48269 (2013.01); A61K 47/48423 (2013.01); A61K 47/48561 (2013.01); C07K 14/555 (2013.01); C07K 14/70575 (2013.01); C07K 16/2878 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); A61K 2039/55522 (2013.01); C07K 2319/33 (2013.01); C07K 2319/40 (2013.01); C07K 2319/74 (2013.01); C12N 2710/16634 (2013.01); C12N 2710/24134 (2013.01);
Abstract

A synergistic adjuvant is provided comprising synergistically effective amounts of at least one type 1 interferon and at least one CD40 agonist, wherein these moieties may be in the same or separate compositions. In addition, fusion proteins and DNA conjugates which contain a type 1 interferon/CD40 agonist/antigen combination are provided. The use of these compositions, protein and DNA conjugates as immune adjuvants for treatment of various chronic diseases such as HIV infection and for enhancing the efficacy of vaccines (prophylactic and therapeutic) is also provided.


Find Patent Forward Citations

Loading…